ArriVent BioPharma
AVBP
#5682
Rank
$0.67 B
Marketcap
$20.10
Share price
-0.25%
Change (1 day)
N/A
Change (1 year)

ArriVent BioPharma (AVBP) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : $0.31 B

According to ArriVent BioPharma's latest financial reports the company's total liabilities are $0.31 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ArriVent BioPharma - Total liabilities on balance sheet (from 2022 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31$0.26 B14638.28%
2021-12-31$1.81 M